22q11.2 deletion testing — MRCPCH TAS MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Chromosomal microarray for 22q11.2 deletion
Conotruncal heart disease, hypocalcaemia and thymic hypoplasia point to 22q11.2 deletion syndrome, now commonly detected by chromosomal microarray. Sweat chloride testing would investigate cystic fibrosis and would not explain T-cell lymphopenia. The key teaching point is that neural crest and pharyngeal pouch development are central to this phenotype.
Reference: RCPCH Theory examination syllabi; Nelson Textbook of Pediatrics; Lissauer's Illustrated Textbook of Paediatrics